Drug Shortage Report for TARO-DEFERASIROX
Report ID | 101320 |
Drug Identification Number | 02463520 |
Brand name | TARO-DEFERASIROX |
Common or Proper name | DEFERASIROX |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | DEFERASIROX |
Strength(s) | 125MG |
Dosage form(s) | TABLET FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | V03AC |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-11-26 |
Estimated end date | 2020-06-30 |
Actual end date | 2020-01-31 |
Shortage status | Resolved |
Updated date | 2020-02-02 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-12-13 | English | Compare |
v2 | 2019-12-13 | French | Compare |
v3 | 2020-02-02 | English | Compare |
v4 | 2020-02-02 | French | Compare |
Showing 1 to 4 of 4